288 related articles for article (PubMed ID: 35876094)
1. Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency.
Zanichelli A; Montinaro V; Triggiani M; Arcoleo F; Visigalli D; Cancian M
Expert Opin Emerg Drugs; 2022 Jun; 27(2):103-110. PubMed ID: 35876094
[TBL] [Abstract][Full Text] [Related]
2. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
3. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Hereditary Angioedema.
Caballero T
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
[TBL] [Abstract][Full Text] [Related]
5. Investigational drugs in phase I and phase II clinical trials for hereditary angioedema.
Farkas H; Debreczeni ML; Kőhalmi KV
Expert Opin Investig Drugs; 2018 Jan; 27(1):87-103. PubMed ID: 29226721
[TBL] [Abstract][Full Text] [Related]
6. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
Wu MA; Zanichelli A; Mansi M; Cicardi M
Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
[TBL] [Abstract][Full Text] [Related]
7. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
8. Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
Wahn V; Aberer W; Aygören-Pürsün E; Bork K; Eberl W; Faßhauer M; Krüger R; Magerl M; Martinez-Saguer I; Späth P; Staubach-Renz P; Weber-Chrysochoou C
Pediatr Allergy Immunol; 2020 Nov; 31(8):974-989. PubMed ID: 32524650
[TBL] [Abstract][Full Text] [Related]
9. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
10. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.
Hide M; Horiuchi T; Ohsawa I; Andresen I; Fukunaga A
Allergol Int; 2021 Jan; 70(1):45-54. PubMed ID: 32919903
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches in hereditary angioedema.
Antoniu SA
Clin Rev Allergy Immunol; 2011 Aug; 41(1):114-22. PubMed ID: 21279474
[TBL] [Abstract][Full Text] [Related]
12. A review of berotralstat for the treatment of hereditary angioedema.
Farkas H; Balla Z
Expert Rev Clin Immunol; 2023 Feb; 19(2):145-153. PubMed ID: 36408587
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
14. Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2.
Fijen LM; Bork K; Cohn DM
Clin Rev Allergy Immunol; 2021 Aug; 61(1):66-76. PubMed ID: 33423210
[TBL] [Abstract][Full Text] [Related]
15. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
16. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
19. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries.
Guo Y; Zhang H; Lai H; Wang H; Chong-Neto HJ; Valle SOR; Zhu R
Orphanet J Rare Dis; 2022 Nov; 17(1):399. PubMed ID: 36324138
[TBL] [Abstract][Full Text] [Related]
20. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
Bork K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]